🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer Just Out on NEJM Inavolisib, a potent and selective inhibitor of the PI3Kα isoform, was evaluated in combination w/ palbociclib💊 and fulvestrant in a phase 3⃣ trial for patients with PIK3CA-mutated🧬, hormone

📢Have you registered? Don't miss our last webinar of 2024‼️ #JohnKisiel from the Mayo Clinic Gastroenterology & Hepatology will🗣️ "New Non-Invasive Colorectal Cancer Screening Tests - Books Beyond Their Covers" 🗓️Tue Nov 19 ⌚️noon ET / 9 am PT ✍️Register👉tinyurl.com/636vnbjh #HereditaryGICancer

Glad to see this data out from our colleagues in #Japan 🇯🇵 Dr. Kataoka #Galaxy trial re: role of #ctDNA in resected #livermets #colorectal #cancer and the benefit of adjuvant chemo in (+) MRD pts for OS. Annals of Oncology Natera Oncology #crcsm OncoAlert pubmed.ncbi.nlm.nih.gov/39293512/

What percent of variants identified on germline testing undergo reclassification? #CGAIGC24

Now an abstract from our friends at Ambry Genetics presented by Jennifer Herrera-Mullar. Patients with CTNNA1 pathogenic variants had no increased risk of lobular breast cancer as compared to controls and lower risk of gastric cancer as compared to CDH1.

Matteo Repetto from Memorial Sloan Kettering Cancer Center presented on patients with MUTYH germline variants who developed cancer and the prevalence of subsequent somatic mutations.

All you've ever wanted to know but never dared to ask about MSH3 management here at CGA-IGC 2024! Food for thought 💭 thanks to Asaf Maoz leading the discussion

November is #PancreaticCancerAwarenessmonth! #CGAIGC24 has some👍talks abt #PancreaticCancer Our Comms Cttee vice chair Kimberly Hilfrank🗣️w/ Dr Fay Kastrino abt the JAMA article "#PancreaticCancer🔍& Survival of High-Risk 🧑‍🤝‍🧑" 📍👂to the interview 👉youtu.be/Y5isMGsDh64

Next up is Kasmintan Schrader from University of British Columbia presenting exciting data on new technology which can identify the parent of origin from a blood sample. Adding precision to familial risk assessment and cascade testing!

Hepatobiliary cancers: germline genetic associations and when to test ⁦Kirk Wangensteen, MD/PhD⁩ #CGAIGC24

Gastrointestinal cancer risks and management in Li-Fraumeni syndrome, great talk by ⁦Kara Maxwell⁩ #CGAIGC24

Genetic discrimination: Updates and implications for genetic counseling, Great presentation by Jennifer Wagner #CGAIGC24

📢We’re thrilled to announce the topics for our 2025 webinar series‼️ As we confirm dates and speakers, we’ll keep our website updated at cgaigc.com/webinars Members will receive regular email invitations to RSVP for the webinars. ➡️Webinars are FREE for members. Not a

📢Registration for Webinar 1 of our 2025 webinar series is now OPEN! 👉 cgaigc.com/webinars ➡️Join us for the first webinar titled “High Impact Papers of 2024,” also featuring our president, Beth Dudley Yurkovich, MS, MPH, CGC, CGAF. Don’t miss out! 🚨Great news for our

📣We're thrilled to partner with Fight Colorectal Cancer again for the 2025 #ColorectalCancerAwarenessMonth! ➡️Learn from our president, Beth Yurkovich Dudley about the importance of this partnership here 👉tinyurl.com/w7ffpwuk 📍Also, see how you can participate this March! Think

📢Join us for the next #HereditaryLive on April 23 at the new time of 12 pm (noon) / 9 am PT‼️ ➡️This time allows our friends & colleagues from EHTGtweets InSiGHT to join this session. 🗓️April 23 ⏱️ 12 pm (noon) ET / 9am PT 📍Add the April #HereditaryLive session to

1/Welcome to #CGAIGCJS Tweetorial on “Neoplasia Detection Through Colonic Surveillance Among Young Individuals With MSH6/PMS2-Associated #LynchSyndrome” by CGA-IGC communications committee member Dan Li Full article in AJG - The American Journal of Gastroenterology at DOI: 10.14309/ajg.0000000000003369

📢May is National Asian American and Pacific Islander (AAPI) Heritage Month—a time to highlight experiences of the AAPI community. ➡️In recognition of this month, Chandrika Kurpad, MS, LCGC a member of our Communications Committee, authored a thoughtful blog post titled "Understanding Barriers to

Dr. Violaine Randrian, a visiting investigator at MSK, spoke about a study that evaluated gene-specific outcomes in individuals with #lynchsyndrome treated with immune checkpoint blockade for advanced #cancer at #ASCO25.

1/Welcome to #CGAIGCJS Tweetorial on “Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working Group” by #CGAIGC Communications Committee member Monika Laszkowska, MD, MS ➡️Full article in